Michael V. O’Shaughnessy

12.7k citations
205 papers · 9.6k · 1 hit paper · h-index 57

Impact in

  • Virology top 0.2%
    • HIV Research and Treatment
    • HIV/AIDS Research and Interventions
    • HIV/AIDS drug development and treatment

Papers in

    • HIV/AIDS Research and Interventions 74
    • HIV/AIDS drug development and treatment 42
    • HIV, Drug Use, Sexual Risk 44
    • Pneumocystis jirovecii pneumonia detection and treatment 9

Michael V. O’Shaughnessy

200 papers receiving 9.1k citations

Michael V. O’Shaughnessy's Hit Papers

Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients 2002 · 469 citations
4690+8+16Years since publication100200300400

Peers

Michael V. O’Shaughnessy
Comparison fields: 5 of 166
  • Virology 2.1k
  • Infectious Diseases 4.4k
  • Emergency Medicine 1.0k
  • Epidemiology 3.6k
  • Hepatology 409
Replace Andrew R. Moss with:
Andrew R. Moss United States
Bruno Spire France
Timothy Flanigan United States
George R. Seage United States
Rochelle P. Walensky United States
Martin T. Schechter Canada
Kelly A. Gebo United States
Ruth M. Greenblatt United States
Pietro Vernazza Switzerland
Kenneth A. Freedberg United States
Michael V. O’Shaughnessy relative to Andrew R. Moss United States Andrew R. Moss's profile →
Citations per field
00.5×1.7×
Andrew R. Moss · 1×
Citations per year

Countries citing papers authored by Michael V. O’Shaughnessy

Since Specialization
Citations

This map shows the geographic impact of Michael V. O’Shaughnessy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael V. O’Shaughnessy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael V. O’Shaughnessy more than expected).

Fields of papers citing papers by Michael V. O’Shaughnessy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael V. O’Shaughnessy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael V. O’Shaughnessy. The network helps show where Michael V. O’Shaughnessy may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael V. O’Shaughnessy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael V. O’Shaughnessy Line = papers co-authored together Michael V. O’Shaughnessy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 205 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients
Hit paper breakdown →
2002469
2 2002362
3 2003342
4 2003308
5
Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
1999257
6
Hospital utilization and costs in a cohort of injection drug users.
2001225
7 2001194
8
Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
2003193
9
Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?
2001188
10
Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
2002184
11
Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
2001181
12
Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.
2003162
13 1998161
14 1989156
15 1997131
16 2004131
17 2002130
18 2002120
19
Leaving hospital against medical advice among HIV-positive patients.
2002119
20 2003117

About Michael V. O’Shaughnessy

Michael V. O’Shaughnessy is a scholar working on Infectious Diseases, Epidemiology, Virology, Surgery and Emergency Medicine, having authored 205 papers that have together received 9.6k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (74 papers), HIV Research and Treatment (56 papers), HIV, Drug Use, Sexual Risk (44 papers), HIV/AIDS drug development and treatment (42 papers), HIV-related health complications and treatments (14 papers), Orthopedic Surgery and Rehabilitation (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers) and T-cell and Retrovirus Studies (7 papers). The work is most often cited by research in Virology (2.1k citations), Infectious Diseases (4.4k citations), Emergency Medicine (1.0k citations), Epidemiology (3.6k citations) and Hepatology (409 citations). Michael V. O’Shaughnessy has collaborated with scholars based in Canada, Ireland and United States. Frequent co-authors include Robert S. Hogg, Martin T. Schechter, Julio Montaner, Mark Tyndall, Evan Wood, Benita Yip, Patricia M. Spittal, Kevin J.P. Craib, Kathy Li and P. Richard Harrigan. Their work appears in journals such as AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, The Journal of Infectious Diseases, The Lancet and Antiviral Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact